KG LEGAL \ INFO
BLOG

Thuringia Meets Małopolska: KG Legal KIELTYKA GLADKOWSKI at the Business Meeting with Minister-President Mario Voigt at SOLARIS

Publication date: November 17, 2026

Kraków, 17 November 2026

Today KG Legal is taking part in a business meeting with a delegation from the Free State of Thuringia, led by Minister-President Mario Voigt, hosted at the National Synchrotron Radiation Centre SOLARIS in Kraków. The meeting is organised by the Polish-German Chamber of Industry and Commerce (AHK Polska) together with the Marshal’s Office of the Małopolska Region and the Business in Małopolska centre, with LEG Thüringen, the Thuringian economic development agency, as a partner.

More

Longevity Washing, AI and the Regulatory Fault Lines of the Longevity Industry: A European Perspective

Publication date: October 12, 2026

I. Introduction

The longevity economy is commonly estimated at several hundred billion dollars worldwide and continues to grow rapidly.[1] Venture capital flows into biotechnology companies that promise to slow, halt, or reverse aging. Clinics from Zurich to Seoul to Miami sell “longevity programmes.” Supplement brands attach the word “longevity” to products ranging from NAD precursors to collagen powders. And yet the word “longevity” does not exist as a legal category in European Union law. There is no definition, no register, no certification scheme, and no authority empowered to decide what may or may not describe itself as a longevity product, a longevity clinic, or a longevity company.

More

Biotech Act – why and for what purpose?

Publication date: February 6, 2026

Some hard numbers reveal the paradox: the EU has a highly developed research sector vs. the EU is a region with a challenging commercialization environment compared to other global leaders.

Biotechnology is one of the fastest-growing research and innovation sectors in the world today, and the European Union plays a significant role in this process. Over the past decade, the number of biotechnology researchers in the EU has nearly doubled, from approximately 42,000 in 2012 to over 81,000 in 2021, and the share of employment in this field has reached 17.2% of total R&D employment. These figures confirm that Europe has a strong scientific base and is systematically building capacity in technologies critical to health, industry, and food security.

More

KG Legal’s article is recommended by the main polish biotechnological media

Biotechnologia.pl, which is the main polish media in biotechnology sector, recommends KG Legal’s article on its homepage.

More

Polish start-ups in new technologies and biotechnology and relevant Polish law

20161205_100129The article was prepared by KG LEGAL KIEŁTYKA GŁADKOWSKI based in Cracow, Poland, specialising in cross border cases, with its focus on new technologies, IT and life science, discusses start-ups, differences between business secret and know-how and the value of these for a company being a start-up, protection of intellectual property, the importance of patent law for start-ups, protection of biotechnological inventions, copyright, the patentability of inventions, protection of IT solutions, procedures for obtaining a patent and rights granted under a patent.

See the link to the article in Polish: http://mojafirma.infor.pl/prawo-autorskie/patent/749659,2,Polskie-startupy-w-IT-i-biotechnologii-ochrona-prawna.html

The information was prepared by Kamil Trzaskoś of KG Legal Polish Law Firm. KG Legal provides specialised legal assistance to IT, Life Science as well as investment processes in Poland and organises networking between Polish and international companies and research centres.

See our specialisations

More

UP